pain drug

pain management pain
Biotech

Lexicon feels the pain as non-opioid data underwhelm investors

The biotech focused on low-dose results, rather than the overall primary endpoint miss, but investors took a much more downbeat view of the data.
Nick Paul Taylor Mar 3, 2025 9:52am
pain addiction pills suffering

Tris shows its opioid alternative is less likely to be abused

Jan 28, 2025 10:53am
pain addiction pills suffering

Tris' opioid alternative reduces post-surgery pain in phase 3

Jan 22, 2025 8:30am
success failure signposts

Vertex's pain prospect underwhelms versus placebo, sinking stock

Dec 19, 2024 7:41am
power lines at dusk

Novo Holdings-backed SiteOne charges up with $100M financing

Dec 18, 2024 7:00am
positive negative up down good bad mixed

Vertex's phase 3 pain trials hit goals but fail to beat Vicodin

Jan 30, 2024 8:00am